Medical Devices

July 29, 2016

Buy ($175)

Companies covered: Mazor Robotics Ltd. (NASDAQ:MZOR), Nuvectra Corporation (NASDAQ:NVTR), Miramar Labs, Inc. (OTCMKTS:MRLB), Myriad Genetics, Inc. (NASDAQ:MYGN), TESARO, Inc. (NASDAQ:TSRO), Thermo Fisher Scientific Inc (NYSE:TMO), Waters Corporation (NYSE:WAT), CEPHEID (NASDAQ:CPHD), Boston Scientific Corporation (NYSE:BSX), Baxter International Inc. (NYSE:BAX), Medtronic, Inc. (NYSE:MDT), Intuitive Surgical, Inc. (NASDAQ:ISRG), Covidien Ltd. (NYSE:COV), Johnson & Johnson (NYSE:JNJ), Abbott Laboratories (NYSE:ABT), C.R. Bard, Inc. (NYSE:BCR), Illumina, Inc. (NASDAQ:ILMN), Cerner Corporation (NASDAQ:CERN), Edwards Lifesciences Corporation (NYSE:EW), St. Jude Medical, Inc. (NYSE:STJ), Hill-Rom Holdings Inc (NYSE:HRC), Cooper Companies, Inc. (The) (NYSE:COO), Teleflex Incorporated (NYSE:TFX)